How long should corticosteroids be discontinued before performing a tuberculin skin test (Mantoux test)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 15, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Tuberculin Skin Testing After Corticosteroid Use

Tuberculin skin testing should ideally be performed before initiating corticosteroid therapy, but if already on steroids, the test is not valid and should be delayed until after discontinuation, though specific wait periods are not well-established in guidelines. 1

Key Guideline Recommendations

Testing Before Immunosuppression

The British Association of Dermatologists guidelines explicitly state that tuberculin testing is not valid in patients already established on immunosuppressive therapy 1. The preferred approach is to perform pretreatment chest X-ray and Mantoux skin test in patients not on immunosuppression 1.

When Steroids Are Already Being Used

  • Current steroid use invalidates TST results - the test should not be relied upon for accurate assessment of latent TB infection 1
  • Consider using Interferon Gamma Release Assays (IGRAs) such as T-SPOT.TB, which may be more sensitive in patients on immunosuppressive drugs, though positive and negative predictive values remain unknown 1

Evidence on Steroid Effects on TST

Systemic Corticosteroids

Research demonstrates that:

  • Recent steroid use significantly suppresses TST positivity - only 3% of patients with recent steroid use tested positive compared to 25% in those who hadn't taken steroids in the last 3 months (p=0.002) 2
  • Steroid usage was significantly associated with negative TST results (39.4% negative rate) 3
  • The immunosuppressive effect is dose and duration dependent

Topical Steroids (Less Relevant)

Even potent topical steroids applied to intact skin can only delay tuberculin reactions but cannot diminish their final size at 48-72 hours 4

Practical Clinical Algorithm

If Patient Is NOT Yet on Steroids:

  1. Perform TST immediately before starting corticosteroids 5
  2. Proceed with steroid therapy after testing

If Patient Is Already on Steroids:

  1. Do not rely on TST results - they will likely be falsely negative 1, 2
  2. Consider IGRA testing instead (T-SPOT.TB or QuantiFERON) as an alternative, though evidence is limited 1
  3. If TST is essential and steroids can be safely stopped:
    • No specific washout period is definitively established in guidelines
    • Based on trial data, at least 4 weeks off systemic therapy was required before biologic initiation in clinical trials 1
    • Consider waiting until immunosuppressive effects have waned (typically several weeks depending on dose and duration)

For High-Risk Patients on Steroids:

  • Patients taking >15 mg prednisone daily for >3 weeks should be considered for TB prophylaxis regardless of testing, especially if living in endemic areas 5
  • Maintain high index of suspicion for TB during and for 6 months after steroid discontinuation 1

Critical Caveats

⚠️ The guidelines do not specify an exact wait period after stopping steroids before TST becomes reliable again. This represents a gap in the evidence.

⚠️ Methotrexate does not significantly affect TST results 2, 3, so the concern is specific to corticosteroids among conventional DMARDs.

⚠️ IGRAs are not perfect alternatives - they show poor agreement with TST even in steroid-naive patients and cannot distinguish active from latent TB 6, 7.

⚠️ Clinical judgment supersedes testing - if TB risk is high (recent exposure, endemic area, immunosuppression), consider empiric treatment for latent TB after excluding active disease with chest X-ray, regardless of test results 1, 5.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.